2022 Revenues ($USD) : $6,710,970,503
2022 Revenues (foreign currencies) : JP¥737,133,000,000
2022 R&D spend : $546,412,964
2022 Number of Employees : 21,898
Fiscal Year End : 3/31/2022
Company CEO : Yasuo Takeuchi, CEO

Tokyo-based Olympus Group makes precision machines and instruments. Its medical devices primarily serve gastroenterology, general surgery, pulmonology, bronchoscopy, urology, gynecology, otolaryngology, bariatrics, orthopedics and anesthesiology. Founded in 1919, the company developed the world’s first gastrocamera in 1950 and now offers endoscopes, endoscope reprocessors, laparoscopes, video imaging systems, system integration solutions and medical services through its Endoscopy unit. Its Therapeutic portfolio includes surgical energy devices and instruments to help prevent, detect and treat disease. There are devices for endotherapy, urology/gynecology, respiratory heath and ear/nose/throat applications. In 2022, Olympus broke off Scientific Solutions — a third business unit outside of Medical Solutions that makes microsocope systems for the life science industry, as well as videoscopes, nondestructive testing technology and X-ray analyzers. Scientific Solutions is now a wholly-owned subsidiary called Evident. –JH